IDEAYA Biosciences
Melissa Fleury is a highly experienced Senior Principal Research Scientist at IDEAYA Biosciences, where responsibilities include leading project teams on undisclosed targets and contributing significantly to the optimization of lead candidates. With a background that includes positions such as Principal Scientist and Senior Research Scientist at IDEAYA, Fleury has been instrumental in the design and synthesis of various lead compounds, particularly in the area of synthetic lethality. Prior experiences at Reset Therapeutics, MyoKardia, Theravance Biopharma, and Theravance involved developing targeted compounds for conditions such as CNS disorders, asthma, hypertension, and heart failure. Fleury's career began with research roles at Gilead Sciences, Shire/BioChem Pharma, Eisai, and the Centre de recherche du CHU de Québec-Université Laval. An academic foundation in Organic Chemistry was established with a Master's degree from The University of British Columbia and a Bachelor's degree in Pharmaceutics and Drug Design from Université de Sherbrooke.
This person is not in any teams
IDEAYA Biosciences
1 followers
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California